A

Allergan

Allergan agreed to pay nearly $30 million to resolve claims it used anti-competitive tactics to raise Restasis prices.

ClosedSelected statesClaim status: Closed on August 11, 2022Payout: VariesNo longer claimable

About this settlement

Alleged antitrust violations involving price increases for Restasis eye drops.

This settlement resolves claims that Allergan used anti-competitive tactics to raise prices on Restasis eye drops. Eligible consumers and third-party payors who purchased Restasis in specified states between May 2015 and July 2021 may receive compensation.

Who qualifies

  • Consumers who purchased Restasis eye drops between May 1, 2015 and July 31, 2021 in eligible states.
  • Third-party payors such as employers and insurers who purchased Restasis in eligible states during the same period.

Varies

Claim status: Closed on August 11, 2022

See active Settlements

Related settlements

Estée Lauder logo

Estée Lauder

No proof required

Up to $5,000

Claims opening soon

Silk and Great Value logo

Silk and Great Value

Proof required

Up to $300,000

96 days left

Audible logo

Audible

No proof required

Compensation pending

Claims opening soon

Government of Canada logo

Government of Canada

Proof required

Up to $200,000

746 days left

Meta (Facebook) logo

Meta (Facebook)

No proof required

Up to $90

Claims opening soon

Ticketmaster logo

Ticketmaster

No proof required

Compensation pending

Claims opening soon